Harmony Biosciences Holdings, Inc. Stock Performance

Open $38.98	Prev. Close $39.33	Circuit Range N/A
Day Range $38.72 - $39.85	Year Range $25.52 - $43.41	Volume 31,081
Average Traded $39.35

Harmony Biosciences Holdings, Inc. Share Price Today

As of 9 October 2026, Harmony Biosciences Holdings, Inc.'s share price is $39.63. The stock opened at $38.98, compared to its previous close of $39.33. During today's trading session, Harmony Biosciences Holdings, Inc.'s share price traded between $38.72 and $39.85, with an average price of $39.29. Over the past 52 weeks, the stock has recorded a high of $43.41 and a low of $25.52. In terms of performance, Harmony Biosciences Holdings, Inc.'s share price has risen by 26.73% over the last six months and is up 38.81% on a year-on-year basis.

Harmony Biosciences Holdings, Inc. Share Price Chart

$38.72$39.85

Harmony Biosciences Holdings, Inc. Stock Fundamentals & Key Indicators

Market Cap $2.28B	PE Ratio (TTM) 12.64	Dividend Yield 0.00%
EPS (TTM) $3.11	Revenue (TTM) $868.45B	Return On Equity (TTM) 18.14%
Profit Margin 18.27%	Debt to Equity 0.15	Quarterly Earnings Growth YoY 48.28%

Harmony Biosciences Holdings, Inc. Quarterly Profit & Loss

All figures in USD

Particulars	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	$239.46	$243.78	$215.39	$261.28
Net Profit	$50.87	$22.49	$32.49	$75.43
Net Profit Margin	21.24%	9.23%	15.08%	28.87%
Income Change	N/A	-55.79%	44.46%	132.16%

Harmony Biosciences Holdings, Inc. Annual Profit & Loss

All figures in USD

Particulars	2022	2023	2024	2025
Revenue	$437.86	$582.02	$714.73	$868.45
Net Profit	$181.47	$128.85	$145.49	$158.69
Net Profit Margin	41.44%	22.14%	20.36%	18.27%
Income Change	N/A	-29.00%	12.91%	9.07%

About Harmony Biosciences Holdings, Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Harmony Biosciences Holdings, Inc. Historical Returns

Month	Open	Close	Change %
Oct 2026	$39.60	$39.64	+0.96%
Sep 2026	$40.20	$39.27	-1.39%
Aug 2026	$34.69	$39.82	+13.08%
Jul 2026	$36.45	$35.22	-3.20%
Jun 2026	$31.30	$36.38	+15.11%
May 2026	$31.50	$31.61	+1.07%
Apr 2026	$28.18	$31.27	+11.68%
Mar 2026	$28.23	$28.00	-1.94%
Feb 2026	$37.24	$28.55	-21.79%
Jan 2026	$37.28	$36.51	-2.35%
Dec 2025	$35.67	$37.39	+5.92%
Nov 2025	$28.62	$35.30	+23.64%

HRMY Share Price FAQs

What is Harmony Biosciences Holdings, Inc. share price today?

Harmony Biosciences Holdings, Inc. share price today is $39.63 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Harmony Biosciences Holdings, Inc. stock?

The 52 week high of Harmony Biosciences Holdings, Inc. stock is $43.41, while the 52 week low is $25.52 as of 9 Oct '26.

What is HRMY's market capitalisation today?

HRMY market capitalisation is $2.28B as of October 9, 2026, at 11:46 am IST.

What is HRMY's net income for the last quarter?

HRMY's net income for the last quarter is 75.43B USD.

What is the 5 year returns of HRMY?

The 5 year returns of HRMY is -4.44% as on 9 Oct '26.

What is the high & low stock price of HRMY today?

HRMY stock price hit a high of $39.85 and low of $38.72 as of 9 Oct '26.

Can I buy HRMY shares in India?

Yes. You can buy HRMY in India by opening an international trading account.